ASEAN Pharmaceutical Regulatory Landscape Report 2016 - Analysis, Technologies & Forecasts - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "ASEAN Pharmaceutical Regulatory Landscape" report to their offering.

This study aims is to analyse the ASEAN pharmaceutical regulatory landscape in terms of the ease of doing business, the impact of harmonisation post AEC 2015, and the key factors and dynamics influencing member countries and the outside world. It also provides strategic recommendations for market participants and conclusions.

An overview of the regulatory environment of each country in ASEAN and a comparison of ease of entry into these countries based on regulatory environment attractiveness are also given. The study provides an in-depth understanding of the following topics: general regulatory environment, product registrationprocess flow, cost of registration, and timeline, pricing regulation, import regulation, and IP rights.

Report Structure:

1. Executive Summary

2. Malaysia

3. Thailand

4. The Philippines

5. Indonesia

6. Vietnam

7. Myanmar

8. Cambodia

9. Singapore

10. Brunei

11. Laos

12. Appendix

For more information visit http://www.researchandmarkets.com/research/w5swz9/asean

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals